Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
27
CTSO Quote, Financials, Valuation and Earnings
Last price:
$0.99
Seasonality move
:
2.57%
Day range:
$1.04 - $1.07
52-week range:
$0.71 - $1.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.70x
P/B ratio:
4.61x
Volume:
18.9K
Avg. volume:
115K
1-year change:
-7.14%
Market cap:
$65.1M
Revenue:
$35.6M
EPS (TTM):
-$0.28
Earnings Data
Next earnings date for CTSO
Aug 13
2025
Most recent earnings per share
-$0.02
Missed by $0.02
(May 14/2025)
Consensus Estimate
--
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CTSO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $10.6M | -- | -- | -- | -- |
| 08/13/2025 | Q2 | $9.8M | -- | -- | -- | -- |
| 05/14/2025 | Q1 | $9M | $8.7M | -$0.02 | -- | -- |
| 03/31/2025 | Q4 | $10.1M | $9.2M | -$0.14 | -- | -- |
| 11/07/2024 | Q3 | $10.2M | $8.6M | -$0.04 | -$0.06 | $0.02 |
| 08/13/2024 | Q2 | $9.7M | $8.8M | -$0.08 | -$0.10 | $0.02 |
| 05/09/2024 | Q1 | $9.8M | $9M | -$0.12 | -$0.12 | $0.00 |
| 03/14/2024 | Q4 | $9.8M | $7.3M | -$0.12 | -$0.11 | -$0.01 |
| 11/09/2023 | Q3 | -- | -- | -$0.21 | -$0.12 | -$0.09 |
| 08/01/2023 | Q2 | -- | -- | -$0.14 | -$0.14 | -$0.00 |
| 05/02/2023 | Q1 | -- | -- | -$0.17 | -$0.13 | -$0.04 |
| 03/09/2023 | Q4 | -- | -- | -$0.01 | -$0.15 | $0.14 |
| 11/03/2022 | Q3 | -- | -- | -$0.28 | -$0.16 | -$0.12 |
| 08/02/2022 | Q2 | -- | -- | -$0.25 | -$0.12 | -$0.13 |
| 05/03/2022 | Q1 | -- | -- | -$0.21 | -$0.14 | -$0.07 |
| 03/08/2022 | Q4 | -- | -- | -$0.21 | -$0.13 | -$0.09 |
| 11/04/2021 | Q3 | -- | -- | -$0.15 | -$0.12 | -$0.03 |
| 08/03/2021 | Q2 | -- | -- | -$0.11 | -$0.05 | -$0.06 |
| 05/04/2021 | Q1 | -- | -- | -$0.10 | -$0.06 | -$0.04 |
| 03/09/2021 | Q4 | -- | -- | -$0.01 | -$0.04 | $0.03 |
| 11/04/2020 | Q3 | -- | -- | -$0.02 | -$0.10 | $0.08 |
| 08/04/2020 | Q2 | -- | -- | -$0.08 | -$0.09 | $0.01 |
| 05/05/2020 | Q1 | -- | -- | -$0.10 | -$0.15 | $0.05 |
| 03/05/2020 | Q4 | -- | -- | -$0.12 | -$0.16 | $0.04 |
| 11/05/2019 | Q3 | -- | -- | -$0.21 | -$0.14 | -$0.07 |
| 08/06/2019 | Q2 | -- | -- | -$0.11 | -$0.15 | $0.04 |
| 05/07/2019 | Q1 | -- | -- | -$0.15 | -$0.18 | $0.03 |
| 03/07/2019 | Q4 | -- | -- | -$0.17 | -$0.13 | -$0.04 |
| 11/06/2018 | Q3 | -- | -- | -$0.10 | -- | -- |
| 08/02/2018 | Q2 | -- | -- | -$0.19 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$0.10 | -- | -- |
| 03/08/2018 | Q4 | -- | -- | -$0.11 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | -$0.07 | -- | -- |
| 08/07/2017 | Q2 | -- | -- | -$0.06 | -- | -- |
| 05/08/2017 | Q1 | -- | -- | -$0.06 | -- | -- |
| 03/03/2017 | Q4 | -- | -- | -$0.19 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.09 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.12 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.07 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.13 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$0.11 | -- | -- |
CytoSorbents Earnings Questions
-
How Much did CytoSorbents Generate in Revenue Last Quarter?
CytoSorbents reported $8.7M worth of top line sales in its most recent quarter.
-
Did CytoSorbents Beat Earnings Last Quarter?
CytoSorbents announced earnings per share of -$0.02 which represents a miss of analyst forecast a -- per share.
-
Is CytoSorbents Profitable?
CytoSorbents reported $6.2M that represents $0.10 per share over the last quarter.
-
What is the Analyst Consensus for CytoSorbents EPS Next Year?
CytoSorbents's earnings are forecast to decrease from -$0.38 per share to -$0.30 per share next year representing a decrease of -53.85%.
-
When is CytoSorbents's Earnings Date?
CytoSorbents's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
